Curcumin gum formulation for prevention of oral cavity head and neck squamous cell carcinoma. (13th November 2018)
- Record Type:
- Journal Article
- Title:
- Curcumin gum formulation for prevention of oral cavity head and neck squamous cell carcinoma. (13th November 2018)
- Main Title:
- Curcumin gum formulation for prevention of oral cavity head and neck squamous cell carcinoma
- Authors:
- Boven, Lindsay
Holmes, Sean P.
Latimer, Brian
McMartin, Kenneth
Ma, Xiaohui
Moore‐Medlin, Tara
Khandelwal, Alok R.
McLarty, Jerry
Nathan, Cherie‐Ann O. - Abstract:
- Abstract : Objectives/Hypothesis: Head and neck squamous cell carcinoma represents the sixth most common cancer. As a result of field cancerization, second primaries and recurrences are high. Hence, research has focused on chemoprevention. Curcumin, a polyphenol compound with anticarcinogenic properties, is one such promising nutraceutical. As poor bioavailability limits curcumin's use, a novel gum formulation was tested allowing for direct mucosal absorption into the bloodstream. This preliminary study validates curcumin gum efficacy by assessing release and transmucosal absorption, along with measuring its effects on serum cytokine levels. Study Design: Clinical trial. Methods: Protocols consisting of initial chew (chewing gum for 30 minutes) and revised chew (alternating chewing and parking gum against buccal mucosa for 30 minutes) were tested in healthy volunteers. High‐performance liquid chromatography measured remnant curcumin in chewed gum, serum, and saliva. Serum levels were assayed for 15 proinflammatory cytokines via multiplex analysis. Results: Revised chew samples demonstrated significantly higher curcumin release and absorption ( P = .0078). Curcumin serum levels were significantly higher at 4 hours in samples > 2.0 g of curcumin release ( P = .01). As saliva levels decreased, a concurrent increase in serum levels was observed, with no significance in the inverse relationship ( P = .1423). When evaluating differences between gender, race, and age, the AsianAbstract : Objectives/Hypothesis: Head and neck squamous cell carcinoma represents the sixth most common cancer. As a result of field cancerization, second primaries and recurrences are high. Hence, research has focused on chemoprevention. Curcumin, a polyphenol compound with anticarcinogenic properties, is one such promising nutraceutical. As poor bioavailability limits curcumin's use, a novel gum formulation was tested allowing for direct mucosal absorption into the bloodstream. This preliminary study validates curcumin gum efficacy by assessing release and transmucosal absorption, along with measuring its effects on serum cytokine levels. Study Design: Clinical trial. Methods: Protocols consisting of initial chew (chewing gum for 30 minutes) and revised chew (alternating chewing and parking gum against buccal mucosa for 30 minutes) were tested in healthy volunteers. High‐performance liquid chromatography measured remnant curcumin in chewed gum, serum, and saliva. Serum levels were assayed for 15 proinflammatory cytokines via multiplex analysis. Results: Revised chew samples demonstrated significantly higher curcumin release and absorption ( P = .0078). Curcumin serum levels were significantly higher at 4 hours in samples > 2.0 g of curcumin release ( P = .01). As saliva levels decreased, a concurrent increase in serum levels was observed, with no significance in the inverse relationship ( P = .1423). When evaluating differences between gender, race, and age, the Asian population showed significantly lower curcumin release and serum levels ( P = .009). CXCL1 (GRO‐α) and TNF‐α were significantly decreased in serum after chewing the gum ( P = .036, P < .001, respectively). Conclusions: Enhanced mucosal contact appears critical in improving curcumin release and absorption. CXCL1 and TNF‐α both represent potential biomarkers for the future study of curcumin chemoprevention. Level of Evidence: 2b Laryngoscope, 129:1597–1603, 2019 … (more)
- Is Part Of:
- Laryngoscope. Volume 129:Number 7(2019)
- Journal:
- Laryngoscope
- Issue:
- Volume 129:Number 7(2019)
- Issue Display:
- Volume 129, Issue 7 (2019)
- Year:
- 2019
- Volume:
- 129
- Issue:
- 7
- Issue Sort Value:
- 2019-0129-0007-0000
- Page Start:
- 1597
- Page End:
- 1603
- Publication Date:
- 2018-11-13
- Subjects:
- Curcumin -- gum -- bioavailability -- release -- chemoprevention -- head and neck squamous cell carcinoma -- high‐performance liquid chromatography -- CXCL1 -- TNF‐α -- premalignant
Otolaryngology -- Periodicals
617.51005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1531-4995/issues ↗
http://www.interscience.wiley.com/jpages/0023-852X ↗
http://www.laryngoscope.com ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/lary.27542 ↗
- Languages:
- English
- ISSNs:
- 0023-852X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5156.200000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 10889.xml